MedPath

The Cardiovascular Prevention Program

Not Applicable
Recruiting
Conditions
Cardiovascular Prevention
Interventions
Other: International Physical Activity Questionnaire
Other: Six minute walking test
Other: SF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21.
Other: MEDAS
Other: Intima-media thickness (IMT)
Biological: Blood sampling
Biological: Stool Sample Culture Test
Registration Number
NCT06362538
Lead Sponsor
Maria Cecilia Hospital
Brief Summary

Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths respectively. In Italy, the situation in terms of deaths due to cardiovascular diseases it is in line with the world ranking and European, being responsible for 44% of all deaths. The only interventional or pharmacological approach is neither effective nor sustainable. The most deaths from cardiovascular diseases are due to atherothrombotic events, which are attributable to a series of risk factors, most of which are modifiable. Turns out itself as a targeted action on these factors with the aim of safeguarding the state of health cardiovascular, may represent the best applicable strategy. It is therefore necessary structure and activate prevention programs aimed at the general population and groups of subjects at higher risk.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • primary prevention: age ≥ 30 years with a negative history of cardiovascular events
  • secondary prevention: age ≥ 30 years with a negative history of cardiovascular events
Exclusion Criteria
  • severe obesity
  • high-grade renal failure
  • severe and/or dialysis
  • oncological disease in active phase
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
subject with a negative or positive history of cardiovascular diseaseStool Sample Culture Testno drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseSF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21.no drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseIntima-media thickness (IMT)no drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseBlood samplingno drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseInternational Physical Activity Questionnaireno drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseSix minute walking testno drugs or devices are included.
subject with a negative or positive history of cardiovascular diseaseMEDASno drugs or devices are included.
Primary Outcome Measures
NameTimeMethod
Adherence to the Mediterranean diet12 months

Mediterranean Diet Adherence

blood glucose test12 months

evaluation of blood glucose

blood pressure measurement12 months

Evaluation of Diastolic Blood Pressure

measure of body mass index12 months

BMI Assessment

blood test to check cholesterol levels12 months

Assessment of hypercholesterolemia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MCH

🇮🇹

Cotignola, Ravenna, Italy

© Copyright 2025. All Rights Reserved by MedPath